|
Market Closed -
Nasdaq
16:00:00 2026-10-13 EDT
|
5-day change | 1st Jan Change | ||
| 59.92 USD | -4.77% |
|
-5.93% | -21.12% |
| 10-08 | RBC Cuts Price Target on PTC Therapeutics to $75 From $85, Keeps Sector Perform Rating | MT |
| 10-07 | PTC Therapeutics Retains Significant Firepower for Bolt-On Deals, RBC Capital Markets Says | MT |
| Market Cap | 5B 4.47B 4.16B 3.78B 7.1B 475B 7.16B 49.88B 19.53B 247B 18.78B 18.37B 792B | P/E 2026 * |
39.8x | P/E 2027 * | 24.1x |
|---|---|---|---|---|---|
| Enterprise Value | 3.13B 2.8B 2.61B 2.36B 4.45B 297B 4.48B 31.22B 12.22B 155B 11.75B 11.5B 496B | EV / Sales 2026 * |
2.49x | EV / Sales 2027 * | 2.08x |
| Free-Float |
92.69% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PTCT | Delayed | |
CBOE
| PTCT | Real-time | |
|
Deutsche Boerse AG
| BH3 | Delayed | |
|
Tradegate
| BH3 | Real-time | |
|
Börse Stuttgart
| BH3 | Delayed | |
|
Boerse Muenchen
| BH3 | Real-time | |
|
Xetra
| BH3 | Delayed |
Last Transcript: PTC Therapeutics, Inc.
| 1 day | -4.77% | ||
| 1 week | -5.93% | ||
| Current month | -7.50% | ||
| 1 month | -9.29% | ||
| 3 months | -26.32% | ||
| 6 months | -14.91% | ||
| Current year | -21.12% |
| 1 week | 59.82 |  | 65.02 |
| 1 month | 59.82 | | 68.84 |
| Current year | 59.82 | | 90.87 |
| 1 year | 59.82 | | 90.87 |
| 3 years | 17.53 | | 90.87 |
| 5 years | 17.53 | | 90.87 |
| 10 years | 4.03 | | 90.87 |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew Klein
CEO | Chief Executive Officer | 54 | 2023-03-21 |
Pierre Gravier
DFI | Director of Finance/CFO | 41 | 2023-07-12 |
| Chief Tech/Sci/R&D Officer | - | 2017-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 74 | 2004-10-31 | |
Allan Jacobson
CHM | Chairman | 80 | 1998-03-30 |
David Southwell
BRD | Director/Board Member | 65 | 2005-11-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/7/26 | Other | Chairman | 0 | 0% | ||
| 10/7/26 | Section Six Partners
| Sell | Company | -2,500 | 0.0030% | |
| 10/6/26 | Exercice | General Counsel | 1,305 | 0.0016% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.77% | -5.93% | -9.29% | +193.87% | 5.25B | |
| -1.36% | +0.78% | +42.36% | +91.48% | 1,054B | |
| -5.73% | -2.42% | +30.23% | +58.50% | 636B | |
| -2.40% | +2.88% | +19.13% | +85.43% | 497B | |
| -2.39% | +0.03% | +65.67% | +36.51% | 359B | |
| -0.06% | +2.86% | +24.03% | +41.07% | 345B | |
| -0.55% | +1.81% | +14.16% | +36.31% | 273B | |
| -1.08% | -0.52% | -6.51% | +8.40% | 246B | |
| -1.13% | +2.54% | +41.19% | +45.32% | 226B | |
| -1.67% | +2.56% | +25.13% | +90.50% | 187B | |
| Average | -1.84% | +2.18% | +24.61% | +68.74% | 382.75B | |
| Weighted average by Cap. | -1.36% | +2.43% | +31.73% | +63.60% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.26B 1.12B 1.05B 948M 1.78B 119B 1.8B 12.52B 4.9B 61.97B 4.71B 4.61B 199B | 1.37B 1.23B 1.14B 1.04B 1.95B 130B 1.96B 13.68B 5.36B 67.71B 5.15B 5.04B 217B |
| Net income | 141M 126M 118M 107M 201M 13.41B 202M 1.41B 552M 6.98B 531M 519M 22.38B | 210M 188M 175M 159M 299M 19.98B 301M 2.1B 822M 10.39B 790M 773M 33.34B |
| Net Debt | -1.87B -1.67B -1.56B -1.41B -2.66B -178B -2.68B -18.66B -7.31B -92.37B -7.03B -6.87B -296B | -2.15B -1.92B -1.79B -1.62B -3.05B -204B -3.07B -21.4B -8.38B -106B -8.06B -7.88B -340B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-13 | US$59.92 | -4.77% | 1,051,412 |
| 26-10-12 | US$62.92 | -2.75% | 745,205 |
| 26-10-09 | US$64.70 | +3.42% | 1,171,187 |
| 26-10-08 | US$62.56 | -1.06% | 1,227,450 |
| 26-10-07 | US$63.23 | -0.74% | 1,040,493 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PTCT Stock
Select your edition
All financial news and data tailored to specific country editions
